Cargando…

Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals

BACKGROUND: Psoriasis is observationally associated with a higher risk of non-alcoholic fatty liver disease (NAFLD); however, the causal relationship between the two diseases remains unclear. OBJECTIVE: We hypothesized that individuals with NAFLD or elevated liver fat content have higher risk of pso...

Descripción completa

Detalles Bibliográficos
Autores principales: Näslund-Koch, Charlotte, Bojesen, Stig Egil, Gluud, Lise Lotte, Skov, Lone, Vedel-Krogh, Signe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638101/
https://www.ncbi.nlm.nih.gov/pubmed/36353626
http://dx.doi.org/10.3389/fimmu.2022.1022460
_version_ 1784825333684371456
author Näslund-Koch, Charlotte
Bojesen, Stig Egil
Gluud, Lise Lotte
Skov, Lone
Vedel-Krogh, Signe
author_facet Näslund-Koch, Charlotte
Bojesen, Stig Egil
Gluud, Lise Lotte
Skov, Lone
Vedel-Krogh, Signe
author_sort Näslund-Koch, Charlotte
collection PubMed
description BACKGROUND: Psoriasis is observationally associated with a higher risk of non-alcoholic fatty liver disease (NAFLD); however, the causal relationship between the two diseases remains unclear. OBJECTIVE: We hypothesized that individuals with NAFLD or elevated liver fat content have higher risk of psoriasis and that NAFLD is a causal risk factor for psoriasis. We tested this using a Mendelian randomization approach. METHODS: We included 108,835 individuals from the Danish general population, including 1,277 individuals with psoriasis and 802 individuals with NAFLD according to ICD codes. To estimate liver fat content, a subset of the participants (N = 7,416) also had a CT scan performed. First, we tested whether a diagnosis of NAFLD or elevated liver fat content was observationally associated with risk of psoriasis. Subsequently, we used the genetic variants PNPLA3 and TM6SF2, both strongly associated with NAFLD and high liver fat content, to test whether NAFLD was causally associated with increased risk of psoriasis. RESULTS: Observationally, individuals with vs. without a diagnosis of NAFLD had higher risk of psoriasis with an odds ratio of 2.03 (95% confidence interval 1.28-3.21). The risk of psoriasis increased in a stepwise manner with increasing liver fat content with an odds ratio of 5.00 (2.63-9.46) in individuals in the highest quartile of liver fat content compared to individuals in the lowest quartile. In genetic analyses, PNPLA3 and TM6SF2 were both associated with increased risk of NAFLD but not with increased risk of psoriasis. CONCLUSION: Observationally, a diagnosis of NAFLD or elevated liver fat content was associated with higher risk of psoriasis. However, using genetic variants as a proxy for NAFLD, we did not find evidence of a causal relationship between NAFLD and psoriasis. Thus, the observational association between NAFLD and psoriasis is presumably a result of shared confounding factors or reverse causation.
format Online
Article
Text
id pubmed-9638101
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96381012022-11-08 Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals Näslund-Koch, Charlotte Bojesen, Stig Egil Gluud, Lise Lotte Skov, Lone Vedel-Krogh, Signe Front Immunol Immunology BACKGROUND: Psoriasis is observationally associated with a higher risk of non-alcoholic fatty liver disease (NAFLD); however, the causal relationship between the two diseases remains unclear. OBJECTIVE: We hypothesized that individuals with NAFLD or elevated liver fat content have higher risk of psoriasis and that NAFLD is a causal risk factor for psoriasis. We tested this using a Mendelian randomization approach. METHODS: We included 108,835 individuals from the Danish general population, including 1,277 individuals with psoriasis and 802 individuals with NAFLD according to ICD codes. To estimate liver fat content, a subset of the participants (N = 7,416) also had a CT scan performed. First, we tested whether a diagnosis of NAFLD or elevated liver fat content was observationally associated with risk of psoriasis. Subsequently, we used the genetic variants PNPLA3 and TM6SF2, both strongly associated with NAFLD and high liver fat content, to test whether NAFLD was causally associated with increased risk of psoriasis. RESULTS: Observationally, individuals with vs. without a diagnosis of NAFLD had higher risk of psoriasis with an odds ratio of 2.03 (95% confidence interval 1.28-3.21). The risk of psoriasis increased in a stepwise manner with increasing liver fat content with an odds ratio of 5.00 (2.63-9.46) in individuals in the highest quartile of liver fat content compared to individuals in the lowest quartile. In genetic analyses, PNPLA3 and TM6SF2 were both associated with increased risk of NAFLD but not with increased risk of psoriasis. CONCLUSION: Observationally, a diagnosis of NAFLD or elevated liver fat content was associated with higher risk of psoriasis. However, using genetic variants as a proxy for NAFLD, we did not find evidence of a causal relationship between NAFLD and psoriasis. Thus, the observational association between NAFLD and psoriasis is presumably a result of shared confounding factors or reverse causation. Frontiers Media S.A. 2022-10-24 /pmc/articles/PMC9638101/ /pubmed/36353626 http://dx.doi.org/10.3389/fimmu.2022.1022460 Text en Copyright © 2022 Näslund-Koch, Bojesen, Gluud, Skov and Vedel-Krogh https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Näslund-Koch, Charlotte
Bojesen, Stig Egil
Gluud, Lise Lotte
Skov, Lone
Vedel-Krogh, Signe
Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
title Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
title_full Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
title_fullStr Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
title_full_unstemmed Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
title_short Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
title_sort non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: a mendelian randomization study of 108,835 individuals
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638101/
https://www.ncbi.nlm.nih.gov/pubmed/36353626
http://dx.doi.org/10.3389/fimmu.2022.1022460
work_keys_str_mv AT naslundkochcharlotte nonalcoholicfattyliverdiseaseisnotacausalriskfactorforpsoriasisamendelianrandomizationstudyof108835individuals
AT bojesenstigegil nonalcoholicfattyliverdiseaseisnotacausalriskfactorforpsoriasisamendelianrandomizationstudyof108835individuals
AT gluudliselotte nonalcoholicfattyliverdiseaseisnotacausalriskfactorforpsoriasisamendelianrandomizationstudyof108835individuals
AT skovlone nonalcoholicfattyliverdiseaseisnotacausalriskfactorforpsoriasisamendelianrandomizationstudyof108835individuals
AT vedelkroghsigne nonalcoholicfattyliverdiseaseisnotacausalriskfactorforpsoriasisamendelianrandomizationstudyof108835individuals